| MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells LS Michel, V Liberal, A Chatterjee, R Kirchwegger, B Pasche, W Gerald, ... Nature 409 (6818), 355-359, 2001 | 943 | 2001 |
| TGF-β: duality of function between tumor prevention and carcinogenesis DR Principe, JA Doll, J Bauer, B Jung, HG Munshi, L Bartholin, B Pasche, ... Journal of the National Cancer Institute 106 (2), djt369, 2014 | 556 | 2014 |
| Role of transforming growth factor beta in cancer B Pasche Journal of cellular physiology 186 (2), 153-168, 2001 | 430 | 2001 |
| Genetic/familial high-risk assessment: breast and ovarian MB Daly, JE Axilbund, S Buys, B Crawford, CD Farrell, S Friedman, ... Journal of the National Comprehensive Cancer Network 8 (5), 562-594, 2010 | 427* | 2010 |
| The platelet function defect of cardiopulmonary bypass [see comments] AS Kestin, CR Valeri, SF Khuri, J Loscalzo, PA Ellis, H MacGregor, ... | 416 | 1993 |
| Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study X Li, S Zhang, Q Zhang, X Wei, Y Pan, J Zhao, X Xin, C Qin, X Wang, J Li, ... The Lancet Oncology 20 (2), 193-201, 2019 | 366 | 2019 |
| Genetic/familial high-risk assessment: breast and ovarian MB Daly, JE Axilbund, S Buys, B Crawford, CD Farrell, S Friedman, ... Journal of the National Comprehensive Cancer Network 8 (5), 562-594, 2010 | 351 | 2010 |
| Transforming growth factor β as a therapeutic target in systemic sclerosis J Varga, B Pasche Nature Reviews Rheumatology 5 (4), 200-206, 2009 | 343 | 2009 |
| TGF-β signaling alterations and susceptibility to colorectal cancer Y Xu, B Pasche Human molecular genetics 16 (R1), R14-R20, 2007 | 337 | 2007 |
| Loss of XIST in breast cancer activates MSN-c-Met and reprograms microglia via exosomal miRNA to promote brain metastasis F Xing, Y Liu, SY Wu, K Wu, S Sharma, YY Mo, J Feng, S Sanders, G Jin, ... Cancer research 78 (15), 4316-4330, 2018 | 262 | 2018 |
| Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study TS Bekaii-Saab, FS Ou, DH Ahn, PM Boland, KK Ciombor, EN Heying, ... The lancet oncology 20 (8), 1070-1082, 2019 | 238 | 2019 |
| TGF-β signaling alterations and colon cancer N Bellam, B Pasche Cancer genetics, 85-103, 2010 | 200 | 2010 |
| Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach A Barbault, FP Costa, B Bottger, RF Munden, F Bomholt, N Kuster, ... Journal of Experimental & Clinical Cancer Research 28 (1), 51, 2009 | 198 | 2009 |
| Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label … A Alistar, BB Morris, R Desnoyer, HD Klepin, K Hosseinzadeh, C Clark, ... The lancet oncology 18 (6), 770-778, 2017 | 195 | 2017 |
| TGFβ signaling in the pancreatic tumor microenvironment promotes fibrosis and immune evasion to facilitate tumorigenesis DR Principe, B DeCant, E Mascariñas, EA Wayne, AM Diaz, N Akagi, ... Cancer research 76 (9), 2525-2539, 2016 | 193 | 2016 |
| TβR-I (6A) is a candidate tumor susceptibility allele B Pasche, P Kolachana, K Nafa, J Satagopan, YG Chen, RS Lo, D Brener, ... Cancer Research 59 (22), 5678-5682, 1999 | 193 | 1999 |
| Cancer cell proliferation is inhibited by specific modulation frequencies JW Zimmerman, MJ Pennison, I Brezovich, N Yi, CT Yang, R Ramaker, ... British journal of cancer 106 (2), 307-313, 2012 | 189 | 2012 |
| Association of MUC16 mutation with tumor mutation load and outcomes in patients with gastric cancer X Li, B Pasche, W Zhang, K Chen JAMA oncology 4 (12), 1691-1698, 2018 | 182 | 2018 |
| The role of the fat mass and obesity associated gene (FTO) in breast cancer risk V Kaklamani, N Yi, M Sadim, K Siziopikou, K Zhang, Y Xu, S Tofilon, ... BMC medical genetics 12, 1-10, 2011 | 173 | 2011 |
| Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk VG Kaklamani, KB Wisinski, M Sadim, C Gulden, A Do, K Offit, JA Baron, ... Jama 300 (13), 1523-1531, 2008 | 168 | 2008 |
